New heart device tested in humans for first time
NCT ID NCT06452589
First seen Mar 02, 2026 · Last updated May 15, 2026 · Updated 15 times
Summary
This early-stage study tests a new device called the FieldForce ablation system for people with atrial fibrillation (an irregular heartbeat). The goal is to see if it is safe and can work as intended. About 35 adults who need a first-time catheter ablation will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL ARRHYTHMIAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Na Homolce Hospital
Prague, 150 00, Czechia
Conditions
Explore the condition pages connected to this study.